MaxCyte Stock

MaxCyte EBITDA Margin

The EBITDA Margin of MaxCyte (MXCT) as of Aug 16, 2026 is -121.82 %. In the previous year, EBITDA Margin was -107.33 % — a change of 13.50% (lower).

EBITDA Margin

-121.82 %

YoY

13.50%

Last updated:

EBITDA Margin of MaxCyte is 2026 -121.82 % . EBITDA Margin of MaxCyte was 2025 -107.33 % . It decreases by 13.50% lower compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

MaxCyte Stock analysis

What does MaxCyte do? MaxCyte Inc is a US biotechnology company specializing in the development of platform-based technologies for the next generation of gene and cell therapies. They offer integrated platform technology for drug manufacturing, research, and development. Their proprietary platform technology, Flow ElectroporationTM, allows for efficient transduction of a variety of cells, making it a valuable tool for the production of CAR-T cell therapies. They also offer services for lentiviral production and customized gene therapy production. MaxCyte has secured $50 million in funding for expansion and has formed important partnerships in the industry. They are a leading player in the development of innovative technologies for gene and cell therapy products. MaxCyte is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MaxCyte stock

EBITDA Margin of MaxCyte is -121.82 % in 2026.

EBITDA Margin of MaxCyte changed from -107.33 % to -121.82 %, representing a 13.50% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA Margin MaxCyte since 2006 – with annual values, charts, and detailed analysis.

EBITDA Margin shows what percentage of revenue converts to EBITDA. It normalizes for depreciation and capital structure differences.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBITDA Margin's MaxCyte with sector peers and the industry average to assess whether it is attractive.

To evaluate EBITDA Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA Margin.

Access this data via the Eulerpool API
Get Free API Key

Margins — MaxCyte

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — MaxCyte